Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure

A report of the southwest pediatric nephrology study group

David R. Powell, Frances Liu, Bonita K. Baker, Raymond L. Hintz, Susan K. Durham, Eileen D. Brewer, James W. Frane, Burkhard Tonshoff, Otto Mehls, Anne Margret Wingen, Sandra L. Watkins, Ronald J. Hogg, Phillip Lee

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Previous studies suggest that growth retardation in children with chronic renal failure (CRF) results in part from inhibition of insulin-like growth factor (IGF) action by excess serum IGF-binding proteins (IGFBPs). Excess IGFBPs in CRF serum include IGFBP-1, -2, and -3 and a diffuse ~24- to 28-kDa IGFBP band identified by [125I]IGF ligand blot. The present studies characterized this diffuse ~24- to 28-kDa band. Initial studies identified this band as IGFBP-6, because it was immunoprecipitated by antiserum raised against a synthetic peptide of human IGFBP-6 (hIGFBP-6). Additional [125I]IGF ligand blots found that the immunoprecipitated band was 1) recognized by [125I]IGF-II but not [125I]IGF-I, 2) more abundant in CRF than in normal serum, and 3) more abundant in serum from dialyzed than nondialyzed prepubertal CRF children. Using the hIGFBP-6 antiserum in a specific and sensitive RIA, we found that serum IGFBP-6 levels were 4.7 ± 1.7 nmol/L in 10 normal prepubertal children, 21.4 ± 6.1 nmol/L in 44 nondialyzed prepubertal CRF children, 73.5 ± 14.4 nmol/L in 7 dialyzed prepubertal CRF children, and 94.6 ± 26.2 nmol/L in 14 dialyzed pubertal CRF children. IGFBP-6 levels were also elevated in 71 nondialyzed European children with CRF. In nondialyzed CRF children, serum IGFBP-6 levels 1) correlated inversely with the glomerular filtration rats, 2) did not correlate with height SD score, and 3) were not altered by 12 months of daily recombinant hGH treatment. In summary, a specific antiserum and RIA were used to demonstrate elevated levels of intact IGF-II-binding IGFBP-6 in serum of CRF children. We postulate that the excess IGFBP-6 may modulate the action of IGF-II on target tissues.

Original languageEnglish (US)
Pages (from-to)2978-2984
Number of pages7
JournalJournal of Clinical Endocrinology and Metabolism
Volume82
Issue number9
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Protein 6
Pediatrics
Nephrology
Chronic Kidney Failure
Serum
Insulin-Like Growth Factor Binding Proteins
Insulin-Like Growth Factor II
Somatomedins
Immune Sera
Blood Proteins
Ligands
Insulin-Like Growth Factor Binding Protein 1
Insulin-Like Growth Factor Binding Protein 2
Insulin-Like Growth Factor I
Rats
Tissue
Carrier Proteins

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure : A report of the southwest pediatric nephrology study group. / Powell, David R.; Liu, Frances; Baker, Bonita K.; Hintz, Raymond L.; Durham, Susan K.; Brewer, Eileen D.; Frane, James W.; Tonshoff, Burkhard; Mehls, Otto; Wingen, Anne Margret; Watkins, Sandra L.; Hogg, Ronald J.; Lee, Phillip.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 82, No. 9, 1997, p. 2978-2984.

Research output: Contribution to journalArticle

Powell, DR, Liu, F, Baker, BK, Hintz, RL, Durham, SK, Brewer, ED, Frane, JW, Tonshoff, B, Mehls, O, Wingen, AM, Watkins, SL, Hogg, RJ & Lee, P 1997, 'Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: A report of the southwest pediatric nephrology study group', Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 9, pp. 2978-2984. https://doi.org/10.1210/jc.82.9.2978
Powell, David R. ; Liu, Frances ; Baker, Bonita K. ; Hintz, Raymond L. ; Durham, Susan K. ; Brewer, Eileen D. ; Frane, James W. ; Tonshoff, Burkhard ; Mehls, Otto ; Wingen, Anne Margret ; Watkins, Sandra L. ; Hogg, Ronald J. ; Lee, Phillip. / Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure : A report of the southwest pediatric nephrology study group. In: Journal of Clinical Endocrinology and Metabolism. 1997 ; Vol. 82, No. 9. pp. 2978-2984.
@article{b8c60bfd3f89455f87e56f22b9ee8614,
title = "Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure: A report of the southwest pediatric nephrology study group",
abstract = "Previous studies suggest that growth retardation in children with chronic renal failure (CRF) results in part from inhibition of insulin-like growth factor (IGF) action by excess serum IGF-binding proteins (IGFBPs). Excess IGFBPs in CRF serum include IGFBP-1, -2, and -3 and a diffuse ~24- to 28-kDa IGFBP band identified by [125I]IGF ligand blot. The present studies characterized this diffuse ~24- to 28-kDa band. Initial studies identified this band as IGFBP-6, because it was immunoprecipitated by antiserum raised against a synthetic peptide of human IGFBP-6 (hIGFBP-6). Additional [125I]IGF ligand blots found that the immunoprecipitated band was 1) recognized by [125I]IGF-II but not [125I]IGF-I, 2) more abundant in CRF than in normal serum, and 3) more abundant in serum from dialyzed than nondialyzed prepubertal CRF children. Using the hIGFBP-6 antiserum in a specific and sensitive RIA, we found that serum IGFBP-6 levels were 4.7 ± 1.7 nmol/L in 10 normal prepubertal children, 21.4 ± 6.1 nmol/L in 44 nondialyzed prepubertal CRF children, 73.5 ± 14.4 nmol/L in 7 dialyzed prepubertal CRF children, and 94.6 ± 26.2 nmol/L in 14 dialyzed pubertal CRF children. IGFBP-6 levels were also elevated in 71 nondialyzed European children with CRF. In nondialyzed CRF children, serum IGFBP-6 levels 1) correlated inversely with the glomerular filtration rats, 2) did not correlate with height SD score, and 3) were not altered by 12 months of daily recombinant hGH treatment. In summary, a specific antiserum and RIA were used to demonstrate elevated levels of intact IGF-II-binding IGFBP-6 in serum of CRF children. We postulate that the excess IGFBP-6 may modulate the action of IGF-II on target tissues.",
author = "Powell, {David R.} and Frances Liu and Baker, {Bonita K.} and Hintz, {Raymond L.} and Durham, {Susan K.} and Brewer, {Eileen D.} and Frane, {James W.} and Burkhard Tonshoff and Otto Mehls and Wingen, {Anne Margret} and Watkins, {Sandra L.} and Hogg, {Ronald J.} and Phillip Lee",
year = "1997",
doi = "10.1210/jc.82.9.2978",
language = "English (US)",
volume = "82",
pages = "2978--2984",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "9",

}

TY - JOUR

T1 - Insulin-like growth factor-binding protein-6 levels are elevated in serum of children with chronic renal failure

T2 - A report of the southwest pediatric nephrology study group

AU - Powell, David R.

AU - Liu, Frances

AU - Baker, Bonita K.

AU - Hintz, Raymond L.

AU - Durham, Susan K.

AU - Brewer, Eileen D.

AU - Frane, James W.

AU - Tonshoff, Burkhard

AU - Mehls, Otto

AU - Wingen, Anne Margret

AU - Watkins, Sandra L.

AU - Hogg, Ronald J.

AU - Lee, Phillip

PY - 1997

Y1 - 1997

N2 - Previous studies suggest that growth retardation in children with chronic renal failure (CRF) results in part from inhibition of insulin-like growth factor (IGF) action by excess serum IGF-binding proteins (IGFBPs). Excess IGFBPs in CRF serum include IGFBP-1, -2, and -3 and a diffuse ~24- to 28-kDa IGFBP band identified by [125I]IGF ligand blot. The present studies characterized this diffuse ~24- to 28-kDa band. Initial studies identified this band as IGFBP-6, because it was immunoprecipitated by antiserum raised against a synthetic peptide of human IGFBP-6 (hIGFBP-6). Additional [125I]IGF ligand blots found that the immunoprecipitated band was 1) recognized by [125I]IGF-II but not [125I]IGF-I, 2) more abundant in CRF than in normal serum, and 3) more abundant in serum from dialyzed than nondialyzed prepubertal CRF children. Using the hIGFBP-6 antiserum in a specific and sensitive RIA, we found that serum IGFBP-6 levels were 4.7 ± 1.7 nmol/L in 10 normal prepubertal children, 21.4 ± 6.1 nmol/L in 44 nondialyzed prepubertal CRF children, 73.5 ± 14.4 nmol/L in 7 dialyzed prepubertal CRF children, and 94.6 ± 26.2 nmol/L in 14 dialyzed pubertal CRF children. IGFBP-6 levels were also elevated in 71 nondialyzed European children with CRF. In nondialyzed CRF children, serum IGFBP-6 levels 1) correlated inversely with the glomerular filtration rats, 2) did not correlate with height SD score, and 3) were not altered by 12 months of daily recombinant hGH treatment. In summary, a specific antiserum and RIA were used to demonstrate elevated levels of intact IGF-II-binding IGFBP-6 in serum of CRF children. We postulate that the excess IGFBP-6 may modulate the action of IGF-II on target tissues.

AB - Previous studies suggest that growth retardation in children with chronic renal failure (CRF) results in part from inhibition of insulin-like growth factor (IGF) action by excess serum IGF-binding proteins (IGFBPs). Excess IGFBPs in CRF serum include IGFBP-1, -2, and -3 and a diffuse ~24- to 28-kDa IGFBP band identified by [125I]IGF ligand blot. The present studies characterized this diffuse ~24- to 28-kDa band. Initial studies identified this band as IGFBP-6, because it was immunoprecipitated by antiserum raised against a synthetic peptide of human IGFBP-6 (hIGFBP-6). Additional [125I]IGF ligand blots found that the immunoprecipitated band was 1) recognized by [125I]IGF-II but not [125I]IGF-I, 2) more abundant in CRF than in normal serum, and 3) more abundant in serum from dialyzed than nondialyzed prepubertal CRF children. Using the hIGFBP-6 antiserum in a specific and sensitive RIA, we found that serum IGFBP-6 levels were 4.7 ± 1.7 nmol/L in 10 normal prepubertal children, 21.4 ± 6.1 nmol/L in 44 nondialyzed prepubertal CRF children, 73.5 ± 14.4 nmol/L in 7 dialyzed prepubertal CRF children, and 94.6 ± 26.2 nmol/L in 14 dialyzed pubertal CRF children. IGFBP-6 levels were also elevated in 71 nondialyzed European children with CRF. In nondialyzed CRF children, serum IGFBP-6 levels 1) correlated inversely with the glomerular filtration rats, 2) did not correlate with height SD score, and 3) were not altered by 12 months of daily recombinant hGH treatment. In summary, a specific antiserum and RIA were used to demonstrate elevated levels of intact IGF-II-binding IGFBP-6 in serum of CRF children. We postulate that the excess IGFBP-6 may modulate the action of IGF-II on target tissues.

UR - http://www.scopus.com/inward/record.url?scp=9844239917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9844239917&partnerID=8YFLogxK

U2 - 10.1210/jc.82.9.2978

DO - 10.1210/jc.82.9.2978

M3 - Article

VL - 82

SP - 2978

EP - 2984

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 9

ER -